ICD10monitor November 13, 2023
Timothy Powell, CPA, CHCP

The Centers for Medicare & Medicaid Services (CMS) has announced a series of proposed changes aimed at enhancing the Medicare Advantage (MA) and Medicare Prescription Drug Benefit Program (Part D). These reforms are in line with a broader economic strategy, often referred to as “Bidenomics,” which emphasizes increasing competition, reducing costs, and ensuring accessible, high-quality healthcare for all Americans.

The proposed regulations intend to help Medicare beneficiaries make more-informed decisions when selecting health coverage plans. A significant aspect of the proposal targets the practices of agents and brokers, ensuring that they prioritize the best interests of enrollees over potential excessive compensation, which can sometimes lead to anti-competitive behavior. This is in direct response to concerns that some MA plans are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage
Growth in Medicare Advantage Raises Concerns
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
A Stronger Medicare Program—Now And Into The Future
Medicare Privatization Is Breaking the Bank

Share This Article